Texas Lotto Frequencies - 477 Draws

car thefts in Avon and Somerset 1998

owners' birthdates thefts days thefts/day expected

May 21-June 21 811 32 25.34 762.5644

April 21-May 20 794 30 26.47 714.9041

June 22-July 23 785 32 24.53 762.5644

July 24-August 23 756 31 24.39 738.7342

March 21-April 20 754 31 24.32 738.7342

February 20-March 20 730 29 25.17 691.074

August 24-September 23 719 31 23.19 738.7342

December 23-January 20 696 29 24.00 691.074

September 24-October 22 686 29 23.66 691.074

January 21-February 19 671 30 22.37 714.9041

October 23-November 22 657 31 21.19 738.7342

November 23-December 22 639 30 21.30 714.9041

8698 365 23.83014

car thefts in Avon and Somerset 1998

owners' birthdates thefts days thefts/day expected

May 21-June 21 811 32 25.34 762.5644

April 21-May 20 794 30 26.47 714.9041

June 22-July 23 785 32 24.53 762.5644

July 24-August 23 756 31 24.39 738.7342

March 21-April 20 754 31 24.32 738.7342

February 20-March 20 730 29 25.17 691.074

August 24-September 23 719 31 23.19 738.7342

December 23-January 20 696 29 24.00 691.074

September 24-October 22 686 29 23.66 691.074

January 21-February 19 671 30 22.37 714.9041

October 23-November 22 657 31 21.19 738.7342

November 23-December 22 639 30 21.30 714.9041

8698 365 23.83014

car thefts in Avon and Somerset 1998

owners' birthdates thefts days thefts/day expected

May 21-June 21 811 32 25.34 762.5644

April 21-May 20 794 30 26.47 714.9041

June 22-July 23 785 32 24.53 762.5644

July 24-August 23 756 31 24.39 738.7342

March 21-April 20 754 31 24.32 738.7342

February 20-March 20 730 29 25.17 691.074

August 24-September 23 719 31 23.19 738.7342

December 23-January 20 696 29 24.00 691.074

September 24-October 22 686 29 23.66 691.074

January 21-February 19 671 30 22.37 714.9041

October 23-November 22 657 31 21.19 738.7342

November 23-December 22 639 30 21.30 714.9041

8698 365 23.83014

Frequency

01020304050607080

Number 4 8 12 16 20 24 28 32 36 40 44 48 52

Texas Lotto Frequencies - 477 Draws

Texas Lotto Frequencies - 477 Draws

Frequency

0

10

20

30

40

50

60

70

80

1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52

Texas Lotto Frequencies - 477 Draws

Frequency

02468

1012141618

35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74

Case 1: Thalidomide

ThalidomideC13H10N2O4

1. Prescribed to pregnant women to combat morning sickness and as an aid to help them sleep.

ThalidomideC13H10N2O4

1. Prescribed to pregnant women to combat morning sickness and as an aid to help them sleep.

2. Sold from 1957 to 1961 in almost fifty countries.

ThalidomideC13H10N2O4

1. Prescribed to pregnant women to combat morning sickness and as an aid to help them sleep.

2. Sold from 1957 to 1961 in almost fifty countries.

3. Inadequate tests were performed to assess the drug's safety: approximately 10,000 children were born with severe malformities.

Testing:

1. Scientists could not find any antibiotic activity, or any other encouraging effects, in mice and rats.

Testing:

1. Scientists could not find any antibiotic activity, or any other encouraging effects, in mice and rats.

2. Seemed to be harmless: outrageously high doses did not kill rodents, rabbits, cats, or dogs.

Testing:

1. Scientists could not find any antibiotic activity, or any other encouraging effects, in mice and rats.

2. Seemed to be harmless: outrageously high doses did not kill rodents, rabbits, cats, or dogs.

3. Although no anticonvulsant effect was found, patients reported experiencing a deep sleep. Other patients said they felt calming and soothing effects.

Testing:

1. Scientists could not find any antibiotic activity, or any other encouraging effects, in mice and rats.

2. Seemed to be harmless: outrageously high doses did not kill rodents, rabbits, cats, or dogs.

3. Although no anticonvulsant effect was found, patients reported experiencing a deep sleep. Other patients said they felt calming and soothing effects.

4. One author later said that “Thalidomide was introduced by the method of Russian Roulette. Practically nothing was known about the drug at the time of its marketing”.

An employee of Chemie Grünenthal brought home samples of the new drug for his pregnant wife, and ten months before thalidomide was put on the market in Germany, on Christmas Day in 1956, their child was born – without ears. Years later, the father learned that his daughter was the first living victim of the epidemic of thalidomide-induced infant malformations and deaths.

Frances Oldham Kelsey, Ph.D., M.D.

Case 2: DES

DESDiethylstilbestrol

C18H20O2

1. First synthesized in early 1938 by English university research funded by the MRC (who had a policy against patenting drugs discovered using public funds).

DESDiethylstilbestrol

C18H20O2

1. First synthesized in early 1938 by English university research funded by the MRC (who had a policy against patenting drugs discovered using public funds).

2. It was inexpensive to synthesize (from coal tar), and was produced by over 300 pharmaceutical companies.

DESDiethylstilbestrol

C18H20O2

1. First synthesized in early 1938 by English university research funded by the MRC (who had a policy against patenting drugs discovered using public funds).

2. It was inexpensive to synthesize (from coal tar), and was produced by over 300 pharmaceutical companies.

3. Its price was kept low from the beginning by competition.

DESDiethylstilbestrol

C18H20O2

1. First synthesized in early 1938 by English university research funded by the MRC (who had a policy against patenting drugs discovered using public funds).

2. It was inexpensive to synthesize (from coal tar), and was produced by over 300 pharmaceutical companies.

3. Its price was kept low from the beginning by competition.

4. DES (in tablets up to 5 mg) was approved by the FDA on September 19, 1941 for 4 indications: gonorrheal vaginitis, atrophic vaginitis, menopausal symptoms, and postpartum lactation suppression.

DESDiethylstilbestrol

C18H20O2

5. In 1941, DES found to be the first effective drug for treatment of metastatic prostate cancer.

DESDiethylstilbestrol

C18H20O2

5. In 1941, DES found to be the first effective drug for treatment of metastatic prostate cancer.

6. It was first prescribed by physicians to prevent miscarriages (in women who had had previous miscarriages) in the 1940s as an off-label use. On July 1, 1947, the FDA approved use for miscarriage.

DESDiethylstilbestrol

C18H20O2

5. In 1941, DES found to be the first effective drug for treatment of metastatic prostate cancer.

6. It was first prescribed by physicians to prevent miscarriages (in women who had had previous miscarriages) in the 1940s as an off-label use. On July 1, 1947, the FDA approved use for miscarriage.

7. In the US, an estimated 5-10 million persons were exposed to DES during 1941-1971, including women who were prescribed DES while pregnant and the female and male children born of these pregnancies.

DESDiethylstilbestrol

C18H20O2

8. In 1960, DES was found to be more effective than androgens in the treatment of advanced breast cancer in postmenopausal women. DES was the hormonal treatment of choice for advanced breast cancer in postmenopausal women for two decades.

DESDiethylstilbestrol

C18H20O2

8. In 1960, DES was found to be more effective than androgens in the treatment of advanced breast cancer in postmenopausal women. DES was the hormonal treatment of choice for advanced breast cancer in postmenopausal women for two decades.

9. In the 1990s, the only approved indications for DES were treatment of advanced prostate cancer and treatment of advanced breast cancer in postmenopausal women.

DESDiethylstilbestrol

C18H20O2

8. In 1960, DES was found to be more effective than androgens in the treatment of advanced breast cancer in postmenopausal women. DES was the hormonal treatment of choice for advanced breast cancer in postmenopausal women for two decades.

9. In the 1990s, the only approved indications for DES were treatment of advanced prostate cancer and treatment of advanced breast cancer in postmenopausal women.

10.The last remaining U.S. manufacturer of DES, Eli Lilly, stopped making and marketing DES in 1997.

Testing

DES was originally considered effective and safe for both the pregnant woman and the developing baby. A double-blind study in 1953 of pregnant women (unselected for history of miscarriage) was not published until six years after DES received FDA approval for prevention of miscarriage. Even though it found that pregnant women given DES had just as many miscarriages and premature deliveries as the control group, DES continued to be aggressively marketed and routinely prescribed (though in decreasing frequency—sales peaked in 1953 and by the late 1960s six of seven leading textbooks of obstetrics said DES was ineffective at preventing miscarriage).

Effects:

First generation:

Women prescribed DES while pregnant are at a modestly increased risk for breast cancer.

Effects:

First generation:

Women prescribed DES while pregnant are at a modestly increased risk for breast cancer.

Second generation:

A new study shows DES daughters as having a 2.5 fold increase in breast cancer after age 40.

Women exposed to DES before birth (in the womb), known as DES Daughters, are at an increased risk for clear cell adenocarcinoma (CCA) of the vagina and cervix, reproductive tract structural differences, pregnancy complications, infertility, and auto-immune disorders. Although DES Daughters appear to be at highest risk for clear cell cancer in their teens and early 20s, cases have been reported in DES Daughters in their 30s and 40s.